Medicine Meets Genetics: Insights into Drug Discovery

This chapter explores how a physician's perspective enhances drug discovery, focusing on the delta 32 polymorphism in the CCR5 gene and its implications for HIV resistance. It also chronicles the challenges and innovations encountered in developing a therapeutic, framed within the context of broader advancements in genetics and genomics research.